Firebird 2 Versus Excel Sirolimus-eluting Stent in Treating Real-world Patients With Coronary Artery Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 570 participants.
Also called NCT01373632
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 570 participants
- Registry
-
NCT01373632
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01373632. Randomized; no masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2012-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Firebird 2 Versus Excel Sirolimus-eluting Stent in Treating Real-world Patients With Coronary Artery Disease
- Acronym
- FESTA
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Firebird 2 sirolimus-eluting stent
- Intervention (Device)
- Excel sirolimus-eluting stent
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
Record details
- Record id
cardio:ct-nct01373632- Content hash
b37f7d5328634af7213b9efc59899cb73426ab0568d2117254b1e9900700dab7